PubMed Health⌕ Search

PubMed · 9476092

Anesthesia systems.

Abstract

This report updates our 1996 Evaluation of systems used to administer inhalation (general) anesthesia (Health Devices 25[5-6], May-June 1996). In that issue, we evaluated a total of six systems (in nine configurations) manufactured by North American Drager (NAD) and Ohmeda. In this Update, we evaluate two additional models--the Cato and the Cicero EM, both of which are manufactured by Dräger Medizintechnik GmbH--according to the same test protocol. In the Conclusions section, we present a complete listing of the anesthesia systems we have evaluated to date in rating and ranking order. As in our original study, we base our conclusions largely on degree of system integration, suitability of the system for various types of procedures, and cost. Dräger Medizintechnik GmbH is the medical division of Drägerwerk AG (Lübeck, Germany), which is also the parent company of U.S.-based NAD--the manufacturer of three of the systems evaluated in our original study. Although both Dräger and NAD sell their products internationally, Drger's products are not sold in North America, and NAD's products are not sold in Germany. Thus, the two products evaluated in this issue are not available in the United States or Canada. This report, however, should be of interest to all our readers, including those in North America, because the newly evaluated systems have advanced features that, in the future, may be available in some form on systems marketed in North America.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

1998. Anesthesia systems.. https://pubmed.ncbi.nlm.nih.gov/9476092/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Role of nitric oxide in the systemic and pulmonary circulation of anesthetized turtles (Trachemys scripta).

In reptiles the influence of local vascular factors on blood flow regulation is vaguely understood. The aim of this study was to investigate the role of nitric oxide (NO) on vascular function in anesthetized Trachemys scripta. The experimental protocol consisted of serial injections of sodium nitroprusside (SNP; 25 microg. kg(-1)), L-arginine (185 mg. kg(-1)) and L-NAME (50 mg. kg(-1)). SNP induced a systemic vasodilation (0.05 to 0.02 kPa. min. kg. mL(-1), P = 0.015), with no change in pulmonary vascular resistance (0.07 versus 0.08 kPa. min. kg. mL(-1), P > 0.05). L-Arg had no effect on resistances but increased cardiac output by 17%. L-NAME increased systemic resistance (33% increase; P = 0.01) while pulmonary resistance was unchanged. These effects are consistent with in vivo and in vitro studies on the systemic vasculature of different reptilian species, suggesting that NO has an important role in maintaining systemic vascular tone. The pulmonary vasculature did not respond to NO due to either a lack of an endogenous NO tone or a relaxed state of the pulmonary vasculature. The importance of NO-based mechanisms versus other neuro-humoral modulators in the reptilian circulation remains uncertain. However, as established in prior studies, cholinergic control of the proximal pulmonary artery is the main regulator of pulmonary resistance while systemic resistance depends on a more complex suite of neural, humoral and local effectors that include NO.

Anesthesia, General↗